Locations:
SearchMore prescriptive system not a concern if patients benefit
In value-based care, the adoption of care paths – standardized, evidence-based treatment regimens – are an important way of improving efficiency and outcomes. But how do physicians react to what might seem a more prescriptive system?
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Very well, if Cleveland Clinic Cancer Center’s experience is an indication. “Our physicians appreciate a care path for a given diagnosis that is state of the art,” Taussig Cancer Institute Chairman Brian J. Bolwell, MD, FACP, says in this video about value-based cancer care. Acceptance “has been surprisingly easy.”
Click here to view more cancer related videos.
Photo Credit ©Russell Lee
Advertisement
Advertisement
First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses
Global R&D efforts expanding first-line and relapse therapy options for patients
Study demonstrates ability to reduce patients’ reliance on phlebotomies to stabilize hematocrit levels
A case study on the value of access to novel therapies through clinical trials
Findings highlight an association between obesity and an increased incidence of moderate-severe disease
Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access 23456
Key learnings from DESTINY trials
Overall survival in patients treated since 2008 is nearly 20% higher than in earlier patients